Pre-existing partner-drug resistance to artemisinin combination therapies facilitates the emergence and spread of artemisinin resistance: a consensus modelling study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pre-existing partner-drug resistance to artemisinin combination therapies facilitates the emergence and spread of artemisinin resistance: a consensus modelling study
Authors
Keywords
-
Journal
Lancet Microbe
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-08-03
DOI
10.1016/s2666-5247(22)00155-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence of Artemisinin-Resistant Malaria in Africa
- (2021) Betty Balikagala et al. NEW ENGLAND JOURNAL OF MEDICINE
- Determinants of MDA impact and designing MDAs towards malaria elimination
- (2020) Bo Gao et al. eLife
- Incorporating genetic selection into individual‐based models of malaria and other infectious diseases
- (2020) Ian M. Hastings et al. Evolutionary Applications
- Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda
- (2020) Aline Uwimana et al. NATURE MEDICINE
- Evaluating the performance of malaria genetics for inferring changes in transmission intensity using transmission modelling
- (2020) Oliver J Watson et al. MOLECULAR BIOLOGY AND EVOLUTION
- Emergence of artemisinin-resistant Plasmodium falciparum with kelch13 C580Y mutations on the island of New Guinea
- (2020) Olivo Miotto et al. PLoS Pathogens
- Impact of seasonal variations in Plasmodium falciparum malaria transmission on the surveillance of pfhrp2 gene deletions
- (2019) Oliver John Watson et al. eLife
- The expected time to cross extended fitness plateaus
- (2019) Mahan Ghafari et al. THEORETICAL POPULATION BIOLOGY
- Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
- (2018) Leila S. Ross et al. Nature Communications
- A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study
- (2017) Benoit Witkowski et al. LANCET INFECTIOUS DISEASES
- Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study
- (2017) Oliver J Brady et al. Lancet Global Health
- The Community As the Patient in Malaria-Endemic Areas: Preempting Drug Resistance with Multiple First-Line Therapies
- (2016) Maciej F. Boni et al. PLOS MEDICINE
- Quantifying the pharmacology of antimalarial drug combination therapy
- (2016) Ian M. Hastings et al. Scientific Reports
- Independent Emergence of thePlasmodium falciparumKelch Propeller Domain Mutant Allele C580Y in Guyana
- (2015) Stella M. Chenet et al. JOURNAL OF INFECTIOUS DISEASES
- Optimum population-level use of artemisinin combination therapies: a modelling study
- (2015) Tran Dang Nguyen et al. Lancet Global Health
- A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
- (2013) Frédéric Ariey et al. NATURE
- Artemisinin Resistance inPlasmodium falciparumMalaria
- (2009) Arjen M. Dondorp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Access to artemisinin combination therapy for malaria in remote areas of Cambodia
- (2008) Shunmay Yeung et al. MALARIA JOURNAL
- Benefits of using multiple first-line therapies against malaria
- (2008) M. F. Boni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started